 Subjective  Still ED, no more LUTS ------------------------ s/p PTAS for bil IIA stenting, no more LUTS/PDE5 inhibitor ------------------------------ ED severe, no response to PDE5i --------------------------------- Pelvic CTA showed bilateral IIA stenoses, continue medical treatment  PCI for bilaterall IIA will be determined next time ------------------------------- angina-free hesitate about PTA, smoking still Continue vascular therapy!! ----------------- Partial response, follow pelvic CTA ----------------- Responsive to medical therapy  Angina-free Continue medical therapy first -------------------------------- Pelvic CTA showed bilateral IIA ostial stenoses bilateral IPA stenoses as well Medical treatment first,  PTA considered next time ---------------------------- Testosterone 3+ ED noted for 1+ year, inadequate response to PDE5 inhibitor HLP, DM DUS LCA decreased Referred from Prof. Hsieh  Objective  20160822RDW-CV: 14.8   %   20160614WBC: 11.57   k/L 20160614RDW-CV: 15.0   %  20160112TG: 188   mg/dL  20151020HbA1c: 6.1   % 20151020TG: 431   mg/dL 20151020T-CHO: 236   mg/dL  20150613HbA1c: 6.1   % 20150613TG: 194   mg/dL  20150528T-CHO: 269   mg/dL 20150528TG: 599   mg/dL  Plan  1. GPT/Cre/GluAC/A1C/Lipid+LDL/UA/Na/K 2. CBC/Testosterone/PSA 3. 10/25 pm         /     M E78.5 Hyperlipidemia    O N52.9 Impotence of organic origin     O I74.3 Periperal arterial occlusive disease                    75 Plavix 75 mg/tab 1 tab QD PO 28 28 tab  2 2016/08/30    :B.6aspirin(stent) 2016/07/25   Bokey EM cap 100 mg/cap 1 cap QD PO 28 28 cap  2 2016/08/30      Lipanthyl Supra FC 160 mg/tab 1 tab QD PO 28 28 tab  2 2016/08/30       Crestor 10 mg/tab 1 tab QOD PO 28 14 tab  2 2016/08/30      Kimodin F.C. 20 mg/tab 1 tab QD PO 28 28 tab  2 2016/08/30      Sustanon inj 250 mg/1 mL /amp 250 mg Q2W IM 28 2 amp  2 2016/08/30                     09026CZP ALT(GPT) 1  N 2016/08/30  Specimen:BLO 2016/10/21     09015CZP Creatinine(Blood) 1  N 2016/08/30  Specimen:BLO 2016/10/21     09005CZP Glucose (AC) 1  N 2016/08/30  Specimen:BLO 2016/10/21     09006C0P HbA1c 1  N 2016/08/30  Specimen:BLO 2016/10/21     09001CZP Cholesterol, Total 1  N 2016/08/30  Specimen:BLO 2016/10/21     09004CZP Triglyceride, TG 1  N 2016/08/30  Specimen:BLO 2016/10/21     09043C0P HDL 1  N 2016/08/30  Specimen:BLO 2016/10/21     09044C0P LDL 1  N 2016/08/30  Specimen:BLO 2016/10/21     09013CZP Uric acid 1  N 2016/08/30  Specimen:BLO 2016/10/21     09021CZP Sodium, Na 1  N 2016/08/30  Specimen:BLO 2016/10/21     09022CZP Potassium, K 1  N 2016/08/30  Specimen:BLO 2016/10/21     08011CZP CBC & platelet 1  N 2016/08/30  Specimen:BLO 2016/10/21     09121B0P Testosterone 1  N 2016/08/30  Specimen:BLO 2016/10/21     12081B0P PSA 1  N 2016/08/30  Specimen:BLO 2016/10/21     20000905 3CC (23G*1+1/4  ) 4  N 2016/08/30  2016/08/30       Subjective  s/p PTAS for bil IIA stenting, no more LUTS/PDE5 inhibitor ------------------------------ ED severe, no response to PDE5i --------------------------------- Pelvic CTA showed bilateral IIA stenoses, continue medical treatment  PCI for bilaterall IIA will be determined next time ------------------------------- angina-free hesitate about PTA, smoking still Continue vascular therapy!! ----------------- Partial response, follow pelvic CTA ----------------- Responsive to medical therapy  Angina-free Continue medical therapy first -------------------------------- Pelvic CTA showed bilateral IIA ostial stenoses bilateral IPA stenoses as well Medical treatment first,  PTA considered next time ---------------------------- Testosterone 3+ ED noted for 1+ year, inadequate response to PDE5 inhibitor HLP, DM DUS LCA decreased Referred from Prof. Hsieh  Objective  20160614WBC: 11.57   k/L 20160614RDW-CV: 15.0   %  20160112TG: 188   mg/dL  20151020HbA1c: 6.1   % 20151020TG: 431   mg/dL 20151020T-CHO: 236   mg/dL  20150613HbA1c: 6.1   % 20150613TG: 194   mg/dL  20150528T-CHO: 269   mg/dL 20150528TG: 599   mg/dL  Plan  1. GPT/Cre/GluAC/A1C/Lipid+LDL/UA/Na/K 2. CBC/Testosterone/PSA 3. 8/30 pm         /     M E78.5 Hyperlipidemia    O I74.3 Periperal arterial occlusive disease    O N52.9 Impotence of organic origin                     75 Plavix 75 mg/tab 1 tab QD PO 28 28 tab   2016/08/02    :A.3aspirin(stent) 2016/07/25   Bokey EM cap 100 mg/cap 1 cap QD PO 28 28 cap   2016/08/02    :() 7    Lipanthyl Supra FC 160 mg/tab 1 tab QD PO 28 28 tab   2016/08/02    :() 7     Crestor 10 mg/tab 1 tab QOD PO 28 14 tab   2016/08/02    :() 7    Kimodin F.C. 20 mg/tab 1 tab QD PO 28 28 tab   2016/08/02    : 7                   09026CZP ALT(GPT) 1  N 2016/08/02  Specimen:BLO 2016/08/22     09015CZP Creatinine(Blood) 1  N 2016/08/02  Specimen:BLO 2016/08/22     09005CZP Glucose (AC) 1  N 2016/08/02  Specimen:BLO 2016/08/22     09006C0P HbA1c 1  N 2016/08/02  Specimen:BLO 2016/08/22     09001CZP Cholesterol, Total 1  N 2016/08/02  Specimen:BLO 2016/08/22     09004CZP Triglyceride, TG 1  N 2016/08/02  Specimen:BLO 2016/08/22     09043C0P HDL 1  N 2016/08/02  Specimen:BLO 2016/08/22     09044C0P LDL 1  N 2016/08/02  Specimen:BLO 2016/08/22     09013CZP Uric acid 1  N 2016/08/02  Specimen:BLO 2016/08/22     09021CZP Sodium, Na 1  N 2016/08/02  Specimen:BLO 2016/08/22     09022CZP Potassium, K 1  N 2016/08/02  Specimen:BLO 2016/08/22     08011CZP CBC & platelet 1  N 2016/08/02  Specimen:BLO 2016/08/22     09121B0P Testosterone 1  N 2016/08/02  Specimen:BLO 2016/08/22     12081B0P PSA 1  N 2016/08/02  Specimen:BLO 2016/08/22       Subjective  ED severe, no response to PDE5i --------------------------------- Pelvic CTA showed bilateral IIA stenoses, continue medical treatment  PCI for bilaterall IIA will be determined next time ------------------------------- angina-free hesitate about PTA, smoking still Continue vascular therapy!! ----------------- Partial response, follow pelvic CTA ----------------- Responsive to medical therapy  Angina-free Continue medical therapy first -------------------------------- Pelvic CTA showed bilateral IIA ostial stenoses bilateral IPA stenoses as well Medical treatment first,  PTA considered next time ---------------------------- Testosterone 3+ ED noted for 1+ year, inadequate response to PDE5 inhibitor HLP, DM DUS LCA decreased Referred from Prof. Hsieh  Objective  20160614WBC: 11.57   k/L 20160614RDW-CV: 15.0   %  20160112TG: 188   mg/dL  20151020HbA1c: 6.1   % 20151020TG: 431   mg/dL 20151020T-CHO: 236   mg/dL  20150613HbA1c: 6.1   % 20150613TG: 194   mg/dL  20150528T-CHO: 269   mg/dL 20150528TG: 599   mg/dL  Plan  8/2 pm         /     M E78.5 Hyperlipidemia    O N52.9 Impotence of organic origin     O I74.3 Periperal arterial occlusive disease                    Bokey EM cap 100 mg/cap 1 cap QD PO 22 22 cap   2016/07/14      Lipanthyl Supra FC 160 mg/tab 1 tab QD PO 22 22 tab   2016/07/14       Crestor 10 mg/tab 1 tab QOD PO 22 11 tab   2016/07/14      Kimodin F.C. 20 mg/tab 1 tab QD PO 22 22 tab   2016/07/14         Subjective  skin lesion on the face (left side of nasal side wall) asymptomatic, color lightened  20160518 For pathology report  Objective  a pea sized skin colored nodule on the left nasal side wall. several variously sized brownish and blackish papules and plaques on the face and four limbs pea sized excoriated papule over right thigh  20160518 Skin, nasal, side wall, left, shave excision, intradermal nevus Skin, forearm, right, excision, inverted follicular keratosis      The specimens are submitted in two separate bottles labeled as A: left nasal side wall and B: right forearm, respectively, fixed in formalin.      Microscopically, section A shows an intradermal nevus.  The section margin is involved.  Section B shows a lesion of inverted follicular keratosis, characterized by a well-defined, inverted and squamous hyperplastic lesion containing squamous eddies and proliferative basaloid cells resembling irritated seborrheic keratosis.  The section margin is free.  Plan  remove stitches         /     M D22.9 Nevus   O L82.1 Seborrheic keratosis                     48025C00 ()10CM 1  N 2016/05/18  2016/05/18       Subjective  skin lesion on the face (left side of nasal side wall) asymptomatic, color lightened  Objective  a pea sized skin colored nodule on the left nasal side wall. several variously sized brownish and blackish papules and plaques on the face and four limbs pea sized excoriated papule over right thigh  Assessment  nevocellular nevus face dermatofibroma right thigh  Plan  well explanation about the risk and benefit of different treatment plans such as observation and excision. shave biopsy left nasal ala excision right thigh         /     M D22.9 Nevus   O D49.2 Skin tumor    O L82.1 Seborrheic keratosis                    C.P. Oint 5 g/tube 1 XX AS ORDER D 7 1 tube   2016/04/28         25004C0W Surgical pathology Level IV 2  N 2016/05/07  :. :. :. 2016/05/07     62010C00 2CM 1  N 2016/04/28  :1 :2016/04/28 11:54 :2016/04/28 12:30 2016/04/28     51027B00 -(SHAVING) 1  N 2016/04/28  2016/04/28     51005C00  1  N 2016/04/28  2016/04/28      Subjective  Pelvic CTA showed bilateral IIA stenoses, continue medical treatment  PCI for bilaterall IIA will be determined next time ------------------------------- angina-free hesitate about PTA, smoking still Continue vascular therapy!! ----------------- Partial response, follow pelvic CTA ----------------- Responsive to medical therapy  Angina-free Continue medical therapy first -------------------------------- Pelvic CTA showed bilateral IIA ostial stenoses bilateral IPA stenoses as well Medical treatment first,  PTA considered next time ---------------------------- Testosterone 3+ ED noted for 1+ year, inadequate response to PDE5 inhibitor HLP, DM DUS LCA decreased Referred from Prof. Hsieh  Objective  20160112TG: 188   mg/dL  20151020HbA1c: 6.1   % 20151020TG: 431   mg/dL 20151020T-CHO: 236   mg/dL  20150613HbA1c: 6.1   % 20150613TG: 194   mg/dL  20150528T-CHO: 269   mg/dL 20150528TG: 599   mg/dL  Plan  1. GPT/Cre/GluAC/A1C/Lipid+LDL/UA/Na/K/CBC 2. Testosterone/PSA 3. 7/14 am (app x 13w)         /     M E78.5 Hyperlipidemia    O I74.3 Periperal arterial occlusive disease    O N52.9 Impotence of organic origin                     Bokey EM cap 100 mg/cap 1 cap QD PO 28 28 cap  3 2016/04/14      Lipanthyl Supra FC 160 mg/tab 1 tab QD PO 28 28 tab  3 2016/04/14    :LDL-C: 83 (2016/01/12)    Crestor 10 mg/tab 1 tab QOD PO 28 14 tab  3 2016/04/14    :LDL-C: 83 (2016/01/12)   Kimodin F.C. 20 mg/tab 1 tab QD PO 28 28 tab  3 2016/04/14                     09026CZP ALT(GPT) 1  N 2016/04/14  Specimen:BLO 2016/06/14     09015CZP Creatinine(Blood) 1  N 2016/04/14  Specimen:BLO 2016/06/14     09005CZP Glucose (AC) 1  N 2016/04/14  Specimen:BLO 2016/06/14     09006C0P HbA1c 1  N 2016/04/14  Specimen:BLO 2016/06/14     09001CZP Cholesterol, Total 1  N 2016/04/14  Specimen:BLO 2016/06/14     09004CZP Triglyceride, TG 1  N 2016/04/14  Specimen:BLO 2016/06/14     09043C0P HDL 1  N 2016/04/14  Specimen:BLO 2016/06/14     09044C0P LDL 1  N 2016/04/14  Specimen:BLO 2016/06/14     09013CZP Uric acid 1  N 2016/04/14  Specimen:BLO 2016/06/14     09021CZP Sodium, Na 1  N 2016/04/14  Specimen:BLO 2016/06/14     09022CZP Potassium, K 1  N 2016/04/14  Specimen:BLO 2016/06/14     08011CZP CBC & platelet 1  N 2016/04/14  Specimen:BLO 2016/06/14     09121B0P Testosterone 1  N 2016/04/14  Specimen:BLO 2016/06/14     12081B0P PSA 1  N 2016/04/14  Specimen:BLO 2016/06/14       /     M Z00.00 Encounter for general adult medical examination without abnormal findings                    00008500 (507521) 1  N 2016/04/14  Specimen:STO 2016/04/14       Subjective  Pelvic CTA showed bilateral IIA stenoses angina-free hesitate about PTA, smoking still Continue vascular therapy!! ----------------- Partial response, follow pelvic CTA ----------------- Responsive to medical therapy  Angina-free Continue medical therapy first -------------------------------- Pelvic CTA showed bilateral IIA ostial stenoses bilateral IPA stenoses as well Medical treatment first,  PTA considered next time ---------------------------- Testosterone 3+ ED noted for 1+ year, inadequate response to PDE5 inhibitor HLP, DM DUS LCA decreased Referred from Prof. Hsieh  Objective  20160112TG: 188   mg/dL  20151020HbA1c: 6.1   % 20151020TG: 431   mg/dL 20151020T-CHO: 236   mg/dL  20150613HbA1c: 6.1   % 20150613TG: 194   mg/dL  20150528T-CHO: 269   mg/dL 20150528TG: 599   mg/dL  Plan  4/14 am         /     M E78.5 Hyperlipidemia    O N52.9 Impotence of organic origin     O I74.3 Periperal arterial occlusive disease                    Bokey EM cap 100 mg/cap 1 cap QD PO 28 28 cap  3 2016/01/21      Lipanthyl Supra FC 160 mg/tab 1 tab QD PO 28 28 tab  3 2016/01/21       Crestor 10 mg/tab 1 tab QOD PO 28 14 tab  3 2016/01/21      Kimodin F.C. 20 mg/tab 1 tab QD PO 28 28 tab  3 2016/01/21        Subjective  Partial response, follow pelvic CTA ----------------- Responsive to medical therapy  Angina-free Continue medical therapy first -------------------------------- Pelvic CTA showed bilateral IIA ostial stenoses bilateral IPA stenoses as well Medical treatment first,  PTA considered next time ---------------------------- Testosterone 3+ ED noted for 1+ year, inadequate response to PDE5 inhibitor HLP, DM DUS LCA decreased Referred from Prof. Hsieh  Objective  20151020HbA1c: 6.1   % 20151020TG: 431   mg/dL 20151020T-CHO: 236   mg/dL  20150613HbA1c: 6.1   % 20150613TG: 194   mg/dL  20150528T-CHO: 269   mg/dL 20150528TG: 599   mg/dL  Plan  1. GPT/Cre/GluAC/A1C/Lipid+LDL/UA/Na/K/CBC 2. 1/21 am  3. Testosterone/PSA 4. Abdominal and pelvic CT scan (with and without contrast), susp. pevlic AOD         /     M 272.4 Hyperlipidemia    O 444.22 Periperal arterial occlusive disease    O 607.84 Impotence of organic origin                    Bokey EM cap 100 mg/cap 1 cap QD PO 28 28 cap  3 2015/10/29      Lipanthyl Supra FC 160 mg/tab 1 tab QD PO 28 28 tab  3 2015/10/29       Crestor 10 mg/tab 1 tab QOD PO 28 14 tab  3 2015/10/29      (DC)Gaster D 20 mg/tab 1 tab QD LZ 28 28 tab  3 2015/10/29                     09026CZP ALT(GPT) 1  N 2015/10/29  Specimen:BLO 2016/01/12     09015CZP Creatinine(Blood) 1  N 2015/10/29  Specimen:BLO 2016/01/12     09005CZP Glucose (AC) 1  N 2015/10/29  Specimen:BLO 2016/01/12     09006C0P HbA1c 1  N 2015/10/29  Specimen:BLO 2016/01/12     09001CZP Cholesterol, Total 1  N 2015/10/29  Specimen:BLO 2016/01/12     09004CZP Triglyceride, TG 1  N 2015/10/29  Specimen:BLO 2016/01/12     09043C0P HDL 1  N 2015/10/29  Specimen:BLO 2016/01/12     09044C0P LDL 1  N 2015/10/29  Specimen:BLO 2016/01/12     09013CZP Uric acid 1  N 2015/10/29  Specimen:BLO 2016/01/12     09021CZP Sodium, Na 1  N 2015/10/29  Specimen:BLO 2016/01/12     09022CZP Potassium, K 1  N 2015/10/29  Specimen:BLO 2016/01/12     08011CZP CBC & platelet 1  N 2015/10/29  Specimen:BLO 2016/01/12     09121B0P Testosterone 1  N 2015/10/29  Specimen:BLO 2016/01/12     12081B0P PSA 1  N 2015/10/29  Specimen:BLO 2016/01/12     33072B5M CT With/Without Contrast-Pelvis 1  N 2015/10/29  Indication:ERECTILE DYSFUNCTION, SUSP. INTERNAL PUDENDAL ARTERY STENOSIS. PLEASE CONSULT DR.  :PROSTATE ERECTILE DYSFUNCTION, SUSP. INTERNAL PUDENDAL ARTERY STENOSIS. PLEASE CONSULT DR.  2016/01/13     33072B3M CT With/Without Contrast-Abdomen 1  N 2015/10/29  Indication:ERECTILE DYSFUNCTION, SUSP. INTERNAL PUDENDAL ARTERY STENOSIS. PLEASE CONSULT DR.  :AORTA ERECTILE DYSFUNCTION, SUSP. INTERNAL PUDENDAL ARTERY STENOSIS. PLEASE CONSULT DR.  2016/01/13     33090B0M NON-IONIC CONTRAST MEDIUM() 1  N 2016/01/13  2016/01/13     20000943 DISPOSABLE SYRINGE KIT 1  N 2016/01/13  2016/01/13       Subjective  Responsive to medical therapy  Angina-free Continue medical therapy first -------------------------------- Pelvic CTA showed bilateral IIA ostial stenoses bilateral IPA stenoses as well Medical treatment first,  PTA considered next time ---------------------------- Testosterone 3+ ED noted for 1+ year, inadequate response to PDE5 inhibitor HLP, DM DUS LCA decreased Referred from Prof. Hsieh  Objective  20150613HbA1c: 6.1   % 20150613TG: 194   mg/dL  20150528T-CHO: 269   mg/dL 20150528TG: 599   mg/dL  Plan  1. GPT/Cre/GluAC/A1C/Lipid+LDL/UA/Na/K/CBC 2. 10/29 pm  3. Testosterone/PSA         /     M 272.4 Hyperlipidemia    O 607.84 Impotence of organic origin    O 444.22 Periperal arterial occlusive disease                    Bokey EM cap 100 mg/cap 1 cap QD PO 28 28 cap  3 2015/08/06      Lipanthyl Supra FC 160 mg/tab 1 tab QD PO 28 28 tab  3 2015/08/06      (DC)Gaster D 20 mg/tab 1 tab QD LZ 28 28 tab  3 2015/08/06                     09026CZP ALT(GPT) 1  N 2015/08/06  Specimen:BLO 2015/10/20     09015CZP Creatinine(Blood) 1  N 2015/08/06  Specimen:BLO 2015/10/20     09005CZP Glucose (AC) 1  N 2015/08/06  Specimen:BLO 2015/10/20     09006C0P HbA1c 1  N 2015/08/06  Specimen:BLO 2015/10/20     09001CZP Cholesterol, Total 1  N 2015/08/06  Specimen:BLO 2015/10/20     09004CZP Triglyceride, TG 1  N 2015/08/06  Specimen:BLO 2015/10/20     09043C0P HDL 1  N 2015/08/06  Specimen:BLO 2015/10/20     09044C0P LDL 1  N 2015/08/06  Specimen:BLO 2015/10/20     09013CZP Uric acid 1  N 2015/08/06  Specimen:BLO 2015/10/20     09021CZP Sodium, Na 1  N 2015/08/06  Specimen:BLO 2015/10/20     09022CZP Potassium, K 1  N 2015/08/06  Specimen:BLO 2015/10/20     08011CZP CBC & platelet 1  N 2015/08/06  Specimen:BLO 2015/10/20     09121B0P Testosterone 1  N 2015/08/06  Specimen:BLO 2015/10/20     12081B0P PSA 1  N 2015/08/06  Specimen:BLO 2015/10/20       Subjective  Pelvic CTA showed bilateral IIA ostial stenoses bilateral IPA stenoses as well Medical treatment first,  PTA considered next time ---------------------------- Testosterone 3+ ED noted for 1+ year, inadequate response to PDE5 inhibitor HLP, DM DUS LCA decreased Referred from Prof. Hsieh  Objective  20150613HbA1c: 6.1   % 20150613TG: 194   mg/dL  20150528T-CHO: 269   mg/dL 20150528TG: 599   mg/dL  Plan  8/6 pm         /     O 607.84 Impotence of organic origin    O 444.22 Periperal arterial occlusive disease    M 272.4 Hyperlipidemia                    Bokey EM cap 100 mg/cap 1 cap QD PO 28 28 cap   2015/07/09      Lipanthyl Supra FC 160 mg/tab 1 tab QD PO 28 28 tab   2015/07/09      (DC)Gaster D 20 mg/tab 1 tab QD LZ 28 28 tab   2015/07/09       Subjective  Testosterone 3+ ED noted for 1+ year, inadequate response to PDE5 inhibitor HLP, DM DUS LCA decreased Referred from Prof. Hsieh  Objective  20150528T-CHO: 269   mg/dL 20150528TG: 599   mg/dL  Plan  1. GPT/Cre/GluAC/A1C/Lipid+LDL/UA/Na/K 2. 7/9 am 3. Abdominal and pelvic CT scan (with and without contrast)         /     M 607.84 Impotence of organic origin    O 444.22 Periperal arterial occlusive disease                    Lipanthyl Supra FC 160 mg/tab 1 tab QOD PO 28 14 tab   2015/06/11                     09015CZP Creatinine (Blood) 1  N 2015/06/11  Specimen:BLO 2015/06/13       09026CZP ALT(GPT) 1  N 2015/06/11  Specimen:BLO 2015/06/13     09005CZP Glucose (AC) 1  N 2015/06/11  Specimen:BLO 2015/06/13     09006C0P HbA1c 1  N 2015/06/11  Specimen:BLO 2015/06/13     09001CZP Cholesterol, Total 1  N 2015/06/11  Specimen:BLO 2015/06/13     09004CZP Triglyceride, TG 1  N 2015/06/11  Specimen:BLO 2015/06/13     09043C0P HDL 1  N 2015/06/11  Specimen:BLO 2015/06/13     09044C0P LDL 1  N 2015/06/11  Specimen:BLO 2015/06/13     09013CZP Uric acid 1  N 2015/06/11  Specimen:BLO 2015/06/13     09021CZP Sodium, Na 1  N 2015/06/11  Specimen:BLO 2015/06/13     09022CZP Potassium, K 1  N 2015/06/11  Specimen:BLO 2015/06/13     33072B3M CT With/Without Contrast-Abdomen 1  N 2015/06/11  Indication:ERECTILE DYSFUNCTION, SUSP. INTERNAL PUDENDAL ARTERY STENOSIS. PLEASE CONSULT DR.  :AORTA ERECTILE DYSFUNCTION, SUSP. INTERNAL PUDENDAL ARTERY STENOSIS. PLEASE CONSULT DR.  2015/07/03     33072B5M CT With/Without Contrast-Pelvis 1  N 2015/06/11  Indication:ERECTILE DYSFUNCTION, SUSP. INTERNAL PUDENDAL ARTERY STENOSIS. PLEASE CONSULT DR.  :PROSTATE ERECTILE DYSFUNCTION, SUSP. INTERNAL PUDENDAL ARTERY STENOSIS. PLEASE CONSULT DR.  2015/07/03     33090B0M NON-IONIC CONTRAST MEDIUM() 1  N 2015/07/03  2015/07/03     20000943 DISPOSABLE SYRINGE KIT 1  N 2015/07/03  2015/07/03      Subjective  ED for 5 yrs and need viagra until half a yr ago, no comorbidity frequent urination for 1-2 yrs, nocturia 2-3  Objective  prostate: enlarged 20150528Prolactin: 8.14   ng/ml 20150528Serum PSA: 0.881   ng/mL 20150528LH: 5.20   mIU/mL 20150528FSH: 4.48   mIU/mL 20150528Testosterone: 3.42   ng/mL 20150528TG: 599   mg/dL 20150528T-CHO: 269   mg/dL           PSV    RI RCA    38.5   0.61 LCA    21.8   0.61  Plan  refer to Dr. Wang PGE1+ DOPPLER(13:30~14:00)         /     M 607.84 Impotence of organic origin    O 600.0 Benign prostatic hypertrophy     O 272.4 Hyperlipidemia                     Caverject 20 mcg/vial 20 mcg QD IL 1 1 vial   2015/06/03                     000G0281  1  Y 2015/06/03  2015/06/03     19015CZ0  1  Y 2015/06/03  2015/06/03       Subjective  ED for 5 yrs and need viagra until half a yr ago, no comorbidity frequent urination for 1-2 yrs, nocturia 2-3  Objective  prostate: enlarged  Plan  PSA, Ac sugar, lipid profile         /     M 607.84 Impotence of organic origin    O 600.0 Benign prostatic hypertrophy                      09125C0P Follicle-stimulating hormone,FSH 1  N 2015/05/27  Specimen:BLO 2015/05/28     09126C0P Luteinizing hormone, LH 1  N 2015/05/27  Specimen:BLO 2015/05/28     27011BZT Prolactin 1  N 2015/05/27  Specimen:BLO 2015/05/28     09121B0P Testosterone 1  N 2015/05/27  Specimen:BLO 2015/05/28     12081B0P PSA 1  N 2015/05/27  Specimen:BLO 2015/05/28     09005CZP Glucose (AC) 1  N 2015/05/27  Specimen:BLO 2015/05/28     09001CZP Cholesterol, Total 1  N 2015/05/27  Specimen:BLO 2015/05/28     09004CZP Triglyceride, TG 1  N 2015/05/27  Specimen:BLO 2015/05/28     09043C0P HDL 1  N 2015/05/27  Specimen:BLO 2015/05/28      
